RNA
#3518
Atrium Therapeutics, Inc. - Common Stock
13.7 2 USD
-0.02%
Market Price
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
Faixa anual
Mudança diária
-1.86%
Mudança mensal
+20.25%
Mudança em 6 meses
-0.65%
Mudança anual
-80.49%
Fechamento anterior
13.9 8
Open
13.6 8
Mínimo
13.6 4
Máximo
13.7 3
Volume
25
Financials
- Market Capitalization 234.69 M
- Employee 391
- Founded 2025
- CEO Troy Wilson
- Website www.aviditybiosciences.com
- Headquarter Delaware, United States
- FIGI BBG01Z0T3959
- Industry Biotecnologia
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 3490 |  NERV Minerva Neurosciences, Inc - Common Stock | 5.13 USD | -5.52% | +2.40% | +19.86% | +111.98% | 244.94 M USD | ||
| 3496 |  PRQR ProQR Therapeutics N.V. - Ordinary Shares | 2.31 USD | -0.43% | -2.12% | +31.25% | +5.00% | 243.38 M USD | ||
| 3526 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 13.57 USD | +0.07% | +7.53% | +35.70% | -9.59% | 232.74 M USD | ||
| 3546 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.89 USD | -2.51% | +0.26% | -0.26% | +23.10% | 229.88 M USD |